IMNM – immunome, inc. (US:NASDAQ)
Stock Stats
News
Immunome Announces Promotion of Max Rosett to Chief Financial Officer [Yahoo! Finance]
Immunome Announces Promotion of Max Rosett to Chief Financial Officer
Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.
Immunome GAAP EPS of -$2.51, revenue of $1.03M [Seeking Alpha]
Immunome Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Form 4 Immunome Inc. For: May 16 Filed by: Rosett Max
Form 424B5 Immunome Inc.
Form 10-Q Immunome Inc. For: Mar 31
Form 8-K Immunome Inc. For: May 14
Form 8-K Immunome Inc. For: Apr 24
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.